CIK 0001613103
- Large accelerated filer
Medtronic plc
Sign in to watch- Ticker
- MDT
- Exchange
- NYSE
- Industry
- Electromedical & Electrotherapeutic Apparatus
- FY end
- Apr 24
- Entity type
- Operating
- Phone
- +353 14381700
- Business address
- BUILDING TWO PARKMORE BUSINESS PARK WEST, GALWAY, Ireland, H91 4K49
- Former names
- Medtronic Ltd, Medtronic Holdings Ltd
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,889,203
- in 3 filings, $5.8M under 10b5-1 plans
Net −$5,889,203. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-09-10 | HAKAMI HOOMAN EVP & Group President Diabetes | Exercise or conversion | +595 | $83.97 | $50K | 31,356 |
| 2019-09-10 | HAKAMI HOOMAN EVP & Group President Diabetes | Sale | −595 | $107.22 | $64K | 30,761 |
| 2019-09-10 | HAKAMI HOOMAN EVP & Group President Diabetes | Exercise or conversion | +14,121 | $89.08 | $1.3M | 44,882 |
| 2019-09-10 | HAKAMI HOOMAN EVP & Group President Diabetes | Sale | −14,121 | $107.41 | $1.5M | 30,761 |
| 2019-09-10 | HAKAMI HOOMAN EVP & Group President Diabetes | Exercise or conversion | +423 | $89.08 | $38K | 31,184 |
| 2019-09-10 | HAKAMI HOOMAN EVP & Group President Diabetes | Sale | −423 | $107.22 | $45K | 30,761 |
| 2019-09-10 | HAKAMI HOOMAN EVP & Group President Diabetes | Exercise or conversion · Stock Option (Right to Buy) | −10,257 | 321 | ||
| 2019-09-10 | HAKAMI HOOMAN EVP & Group President Diabetes | Exercise or conversion · Stock Option (Right to Buy) | −321 | 0 | ||
| 2019-09-10 | HAKAMI HOOMAN EVP & Group President Diabetes | Exercise or conversion · Stock Option (Right to Buy) | −27,254 | 9,085 | ||
| 2019-09-10 | HAKAMI HOOMAN EVP & Group President Diabetes | Exercise or conversion · Stock Option (Right to Buy) | −852 | 284 | ||
| 2019-09-10 | HAKAMI HOOMAN EVP & Group President Diabetes | Exercise or conversion · Stock Option (Right to Buy) | −19,054 | 19,055 | ||
| 2019-09-10 | HAKAMI HOOMAN EVP & Group President Diabetes | Exercise or conversion · Stock Option (Right to Buy) | −595 | 596 | ||
| 2019-09-10 | HAKAMI HOOMAN EVP & Group President Diabetes | Exercise or conversion · Stock Option (Right to Buy) | −14,121 | 42,364 | ||
| 2019-09-10 | HAKAMI HOOMAN EVP & Group President Diabetes | Exercise or conversion · Stock Option (Right to Buy) | −423 | 1,272 | ||
| 2019-08-05 | Lerman Bradley E SVP General Counsel & Corp Sec | Sale | −4,000 | $100.31 | $401K | 52,906 |
| 2019-08-02 | Lerman Bradley E SVP General Counsel & Corp Sec | Sale | −6,599 | $102.02 | $673K | 56,906 |
| 2019-08-02 | Kuntz Richard SVP & Chief Medical & Science | Sale | −5,719 | $102.02 | $583K | 100,241 |
| 2019-08-01 | WHITE ROBERT JOHN EVP & President MITG | Shares withheld for taxes | −2,846 | $102.37 | $291K | 57,253 |
| 2019-08-01 | WHITE ROBERT JOHN EVP & President MITG | Shares withheld for taxes | −5,336 | $102.37 | $546K | 51,917 |
| 2019-08-01 | TEN HOEDT ROB EVP & President EMEA | Shares withheld for taxes | −3,510 | $102.37 | $359K | 64,529 |
Page 46 of 49 · 966 trades